1652561-87-9|(3S,6S,9S,12S,15S,21S)-1-((2S,5S,8S,11S,20S)-20-((6S,9S,12S,15S,21S)-6-Acetamido-1-amino-12,15-dibenzyl-21-((S)-sec-butyl)-9-(3-guanidinopropyl)-1-imino-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosanamido)-8-(2-amino-2-oxoethyl)-5-((R)-1-hydroxyethyl)-2-isobutyl-11,20-dimethyl-3,6,9,21-tetraoxo-1,4,7,10-tetraazacyclohenicos-15-en-11-yl)-21-(2-amino-2-oxoethyl)-6-(4-aminobutyl)-12,15-bis(2-carboxyethyl)-9-((R)-1-hydroxyethyl)-3-isobutyl-1,4,7,10,13,16,19-heptaoxo-2,5,8,11,14,17,20-heptaazadocosan-22-oic acid|BLD Pharm

Startseite/ Inhibitors/Agonists/ Stapled Peptide/ SOS1/KRAS (stapled peptide)/(3S,6S,9S,12S,15S,21S)-1-((2S,5S,8S,11S,20S)-20-((6S,9S,12S,15S,21S)-6-Acetamido-1-amino-12,15-dibenzyl-21-((S)-sec-butyl)-9-(3-guanidinopropyl)-1-imino-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosanamido)-8-(2-amino-2-oxoethyl)-5-((R)-1-hydroxyethyl)-2-isobutyl-11,20-dimethyl-3,6,9,21-tetraoxo-1,4,7,10-tetraazacyclohenicos-15-en-11-yl)-21-(2-amino-2-oxoethyl)-6-(4-aminobutyl)-12,15-bis(2-carboxyethyl)-9-((R)-1-hydroxyethyl)-3-isobutyl-1,4,7,10,13,16,19-heptaoxo-2,5,8,11,14,17,20-heptaazadocosan-22-oic acid

(3S,6S,9S,12S,15S,21S)-1-((2S,5S,8S,11S,20S)-20-((6S,9S,12S,15S,21S)-6-Acetamido-1-amino-12,15-dibenzyl-21-((S)-sec-butyl)-9-(3-guanidinopropyl)-1-imino-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosanamido)-8-(2-amino-2-oxoethyl)-5-((R)-1-hydroxyethyl)-2-isobutyl-11,20-dimethyl-3,6,9,21-tetraoxo-1,4,7,10-tetraazacyclohenicos-15-en-11-yl)-21-(2-amino-2-oxoethyl)-6-(4-aminobutyl)-12,15-bis(2-carboxyethyl)-9-((R)-1-hydroxyethyl)-3-isobutyl-1,4,7,10,13,16,19-heptaoxo-2,5,8,11,14,17,20-heptaazadocosan-22-oic acid *Cold-chain transportation

CAS NO.： 1652561-87-9

Größe	Preis	Verkaufsrabatt	Rabatt	Lager-CN	Lager-US	Lager-IND	Lager-EU	Menge

How to Order +86-21-61629022 sales@bldpharm.com tech@bldpharm.com Catalog

The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

How to Order

PRODUKT INFORMATION

Produktdetails
Sicherheit

Produkt Name :	(3S,6S,9S,12S,15S,21S)-1-((2S,5S,8S,11S,20S)-20-((6S,9S,12S,15S,21S)-6-Acetamido-1-amino-12,15-dibenzyl-21-((S)-sec-butyl)-9-(3-guanidinopropyl)-1-imino-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosanamido)-8-(2-amino-2-oxoethyl)-5-((R)-1-hydroxyethyl)-2-isobutyl-11,20-dimethyl-3,6,9,21-tetraoxo-1,4,7,10-tetraazacyclohenicos-15-en-11-yl)-21-(2-amino-2-oxoethyl)-6-(4-aminobutyl)-12,15-bis(2-carboxyethyl)-9-((R)-1-hydroxyethyl)-3-isobutyl-1,4,7,10,13,16,19-heptaoxo-2,5,8,11,14,17,20-heptaazadocosan-22-oic acid
CAS Nr. :	1652561-87-9	Molekulargewicht :	2187.50
MDL Nr. :	N/A	Feinheit/Spezifikation :
Molekularformel :	C₁₀₀H₁₅₉N₂₇O₂₈	Lagerung :	-
Siedepunkt :	-

GHS Pictogram :
Signal Word :		Precautionary Statements :
UN# :	N/A	Class :	N/A
Hazard Statements :	-	Packing Group :	N/A

PRODUKT INFORMATION

ZUSAMMENHÄNGENDE PRODUKTE

HISTORISCHE AUFZEICHNUNGEN

Kontakt